Pyridoxine hydrochloride
Sponsors
Oslo University Hospital HF, National Institute of Allergy and Infectious Diseases (NIAID), Case Comprehensive Cancer Center, Alliance for Clinical Trials in Oncology, National Cancer Centre, Singapore
Conditions
Autism Spectrum DisordersBreast CancerChild MalnutritionColorectal CancerComorbidities and Coexisting ConditionsDermatologic ComplicationsDrug/Agent Toxicity by Tissue/OrganEndometrial Cancer
Phase 1
Phase 2
Phase 3
The Treatment of Tuberculosis in HIV-Infected Patients
CompletedNCT00001033
End: 1997-07-31Target: 650Updated: 2021-11-04
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer
CompletedNCT00245050
Start: 2004-04-30End: 2011-09-30Updated: 2011-12-30
Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer
CompletedNCT00296036
Start: 2006-06-30Updated: 2017-03-16
Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer
TerminatedNCT00486213
Start: 2007-06-30End: 2014-08-31Updated: 2015-09-24
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer
NCT00559858
Start: 2004-12-31Target: 270Updated: 2013-08-02
An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM
Active, not recruitingNCT05994742
Start: 2024-07-15End: 2026-08-15Updated: 2026-03-19
Unknown Phase
Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
CompletedNCT00000950
Target: 50Updated: 2011-03-02
Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
CompletedNCT00000638
End: 1999-09-30Target: 2000Updated: 2021-11-02
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
CompletedNCT00000796
End: 1998-10-31Target: 525Updated: 2021-11-03
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
CompletedNCT00000636
End: 1997-10-31Target: 2000Updated: 2021-11-02
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection
CompletedNCT00000959
End: 1996-06-30Target: 600Updated: 2021-11-04
Early Nutritional Intervention in Patients With Autism Spectrum Disorders
CompletedNCT01230359
Start: 2010-04-30End: 2011-07-31Updated: 2011-07-19